Mixed Martial Arts Group Ltd
MMA NYSE Services-Miscellaneous Business Services Financials FY2022–FY2025
What Mixed Martial Arts Group Ltd does
No business description yet.
- Legal name
- MIXED MARTIAL ARTS GROUP LTD
- Fiscal year ends
- June 30, 2025
- Latest annual report
- 20-F · Oct 31, 2025
- Accession · CIK
- 0001493152-25-020434
0001981519
Revenue and margins
Mixed Martial Arts Group Ltd had $1.4M of revenue in fiscal 2025, up 145.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$8.3M in fiscal 2025, −603.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Mixed Martial Arts Group Ltd returned — to shareholders in fiscal 2025. The diluted share count rose 27.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Mixed Martial Arts Group Ltd can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $0.6M | $3.7M | $3.5M | $2.1M |
| Current ratio | — | 0.2x | 1.4x | 0.3x |
| Quick ratio | — | 0.2x | 1.4x | 0.3x |
| Total assets | — | $7.2M | $5.3M | $6.8M |
| Total liabilities | — | $38.4M | $2.8M | $8.2M |
| Shareholders' equity | −$12.9M | −$31.1M | $2.6M | −$1.4M |
| Net debt (− = net cash) | — | — | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✕ | ✕ |
| Cash from operations is positive | ✕ | ✕ | ✕ | ✕ |
| Return on assets rose | — | — | ✓ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | — | — | — |
| Current ratio rose | — | — | ✓ | ✕ |
| Share count didn't rise | — | ✓ | ✕ | ✕ |
| Gross margin rose | — | — | — | — |
| Revenue rose relative to assets | — | — | ✕ | ✓ |
| F-score | — / 3 | — / 4 | 3 / 7 | 2 / 7 |
| Accruals ratio | — | −208.7% | −80.9% | −292.9% |
| Altman Z'' | — | — | — | — |
4 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $0.9M | $1.5M | $0.6M | $1.4M |
| Interest expense | $2.2M | −$4.5M | −$3.3M | −$0.3M |
| Pretax income | −$11.2M | $20.6M | $14.4M | $26.0M |
| Net income | −$11.2M | −$20.6M | −$14.4M | −$26.0M |
| Diluted EPS | −$2.86 | −$5.26 | −$1.40 | −$1.99 |
| Diluted shares | 0.00B | 0.00B | 0.01B | 0.01B |
| Cash flow | ||||
| Cash from operations | −$8.1M | −$5.5M | −$9.3M | −$8.3M |
| Capital expenditure | $0.1M | $0.0M | $0.0M | $0.0M |
| Free cash flow | −$8.1M | −$5.5M | −$9.3M | −$8.3M |
| Stock-based compensation | $1.5M | $2.4M | $4.5M | $9.7M |
| Balance sheet | ||||
| Cash and short-term investments | $0.6M | $3.7M | $3.5M | $2.1M |
| Current assets | — | $6.1M | $3.6M | $2.1M |
| Current liabilities | — | $28.0M | $2.6M | $6.3M |
| Property and equipment, net | — | $0.1M | $0.1M | $0.1M |
| Intangible assets | — | $0.8M | $1.3M | $4.4M |
| Total assets | — | $7.2M | $5.3M | $6.8M |
| Total liabilities | — | $38.4M | $2.8M | $8.2M |
| Shareholders' equity | −$12.9M | −$31.1M | $2.6M | −$1.4M |
| Margins | ||||
| Net margin | −1,190.2% | −1,340.3% | −2,562.4% | −1,888.2% |
| FCF margin | −862.5% | −359.1% | −1,662.7% | −603.1% |
| Returns | ||||
| Return on equity | — | — | — | −4,421.3% |
| Return on assets | — | −284.9% | −229.6% | −430.3% |
| Return on tangible equity | — | — | −1,142.4% | — |
| Growth | ||||
| Revenue growth | — | 63.4% | −63.4% | 145.0% |
| Share count change | — | 0.0% | 162.0% | 27.0% |
| Financial health | ||||
| Current ratio | — | 0.2x | 1.4x | 0.3x |
| Quick ratio | — | 0.2x | 1.4x | 0.3x |
| Capital allocation | ||||
| Capex / revenue | 6.3% | 1.0% | 3.3% | 0.2% |
| Stock comp / revenue | 164.4% | 153.9% | 804.1% | 705.1% |
| Quality scores | ||||
| Piotroski F-score | — | — | 3.0 | 2.0 |
| Accruals ratio | — | −208.7% | −80.9% | −292.9% |
Source: SEC EDGAR XBRL filings (CIK 0001981519). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.